
The structure shown is that of Mechlorethamine, which is an alkylating agent commonly used in chemotherapy. It contains two chlorine atoms (Cl) attached to the nitrogen of an ethylene diamine group. This chemical structure is characteristic of Mechlorethamine, also known as Mustine, which is used in the treatment of various cancers, including lymphomas and leukemias.
Why Other Options Are Incorrect:
- (B) Chlorambucil: Although Chlorambucil is also an alkylating agent, its structure differs by having an aromatic ring and a different substitution pattern compared to Mechlorethamine.
- (C) Vincristine: Vincristine is a vinca alkaloid used in chemotherapy but has a completely different structure, containing a complex ring system.
- (D) 6-Mercaptopurine: 6-Mercaptopurine is a purine analog, not an alkylating agent, and its structure does not resemble the one shown.
Thus, the correct drug name for the given structure is Mechlorethamine.
This question shows a drug structure and asks it to be identified as one of four well known anticancer agents. Each of the four drugs belongs to a different structural class, so matching the class the structure belongs to is the fastest way to the answer.
The bis-chloroethylamine arrangement centred on a simple aliphatic nitrogen, without an aromatic ring or complex fused system, is characteristic of mechlorethamine among these four options.
Therefore, the correct answer is Mechlorethamine.
| List I-Mechanism of action | List II-Drugs | ||
| A | DPP4 inhibitors | I | Metformin |
| B | KATP Channel blocker | II | Pioglitazone |
| C | PPAR activator | III | Glimepiride |
| D | AMP Activator | IV | Teneligliptin |
| E | - | V | α glucosidase inhibitors |
Choose the correct answer from the options given below:
| List I | List II | ||
| A | Phase‐I | I | Post marketing surveillance |
| B | Phase‐0 | II | Micro dosing |
| C | Phase‐3 | III | First in human dose |
| D | Phase‐4 | IV | Multicentric trials |
Choose the correct answer from the options given below:
| List I-Mechanism of action | List II-Drugs | ||
| A | DPP4 inhibitors | I | Metformin |
| B | KATP Channel blocker | II | Pioglitazone |
| C | PPAR activator | III | Glimepiride |
| D | AMP Activator | IV | Teneligliptin |
| E | - | V | α glucosidase inhibitors |
Choose the correct answer from the options given below:
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |